EMILY BASARABESCU: Open Payments
NPI 1043507528 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 11 payments from 7 companies in 2025. Trend: 2023 $934 · 2024 $1,079 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $61 |
| Novo Nordisk Inc | 3 | $58 |
| PFIZER INC. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: Ozempic, ELIQUIS, VRAYLAR, QULIPTA, VOQUEZNA, TAVNEOS, AIRSUPRA, XIFAXAN.
Industry payments across MO — which companies pay providers there.
